Dr. Samuel W. Mietling, MD

Dr. Mietling practices at Institute for Minimally Invasive Therapies Surgery Center in Atlanta, Georgia.

Dr. Mietling's NPI, 1750347589, was assigned on April 21, 2006. Dr. Mietling graduated from University of North Carolina School of Medicine in 1985. Dr. Mietling holds Georgia license 051686.

Dr. Mietling's primary practice is Institute for Minimally Invasive Therapies Surgery Center, at 250 East Ponce De Leon Avenue, Atlanta, GA 30030. The practice phone is (404) 377-9171.

Dr. Mietling's primary practice is Institute for Minimally Invasive Therapies Surgery Center in Atlanta, Georgia. The medical group on file is Institute for Minimally Invasive Therapies (IMIT). Dmand AI also links Dr. Mietling to 3 more medical groups and 2 ambulatory surgery centers, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mietling practices, 3 sites in all. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. Mietling's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dr. Mietling is board certified in interventional radiology and diagnostic radiology by the American Board of Radiology. Dmand AI has Dr. Mietling's licenses on file in 5 states: Georgia, Florida, Alabama, South Carolina and North Carolina.

CMS data shows 646 Medicare services from Dr. Mietling across 13 procedure codes in 2024, for 185 Medicare patients. Medicare paid $49,245 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 185 Medicare patients who saw Dr. Mietling in 2024. The largest group is under 65, with 76 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 37% are also on Medicaid. Their average risk score is 9.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mietling's median patient age at 66, with 43% women.

In 2024, Dr. Mietling wrote 11 Medicare Part D claims. 100% of them were for generic drugs. They cover 1 drug, with $114 in total drug cost. In 2019, CMS named 55 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 68 out of 100 for Dr. Mietling for performance year 2024, reported as part of a group. Dr. Mietling accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Mietling in 2016. The most frequent topics are Angioplasty, Balloon, Arteriovenous Shunt, Surgical and Graft Occlusion, Vascular. Dr. Mietling's most frequent co-authors are Ziv J. Haskal, MD, Randy I. Cooper, MD and Bart Lewis Dolmatch, MD.

Dmand AI links Dr. Mietling to 1 clinical trial. Conditions studied include Peripheral Arterial Disease and Peripheral Vascular Diseases.

CMS Open Payments shows 71 general payments to Dr. Mietling from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 82% of the total. Volcano Corporation paid the most, $660.

Dr. Mietling graduated from University of North Carolina School of Medicine in 1985.

Dr. Mietling is in network with 11 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.